FLUKE
Kimball Electronics
Tolomatic
Industrial Scientific
AHEAD
roboception
FLUKE
Kimball Electronics
Tolomatic
Industrial Scientific
AHEAD
roboception
By Deepa Shetty | Wed Sep 3 2025 | 2 min read

Table of Contents

The PFAS compliance gauntlet just got thrown down harder and it’s not optional anymore. On 20 August 2025, the European Chemicals Agency (ECHA) dropped the 14th version of its PFAS Background Document under REACH, incorporating over 5,600 stakeholder comments and adding eight new industry sectors now in the crosshairs. Meanwhile, a new “controlled‑use” path offers limited exemptions—but only under a microscope of strict risk controls. This isn’t a drill. If you're in electronics, textiles, pharma, or defense, your compliance roadmap just got a full‑length rewrite.

What’s Changed: Key Updates in the Background Document

  • Version 14 released on 20 August 2025, reflecting deep analysis of input from Denmark, Germany, the Netherlands, Norway, and Sweden
  • Eight additional sectors now assessed, expanding the scope beyond the original proposal to include:
    • Printing applications
    • Sealing systems
    • Machinery operations
    • Medical uses like pharmaceutical packaging and excipients
    • Military and explosive applications
    • Technical textiles
    • Broad industrial uses (e.g., solvents, catalysts)
  • New "alternative restriction options" introduced, allowing controlled PFAS use in specific cases subject to stringent risk controls. These include:
    • PFAS manufacturing
    • Transport
    • Electronics & semiconductors
    • Energy sectors
    • Sealing and machinery applications
    • Technical textiles.
  • ECHA has outlined potential PFAS thresholds for enforceable use:
    • 25 ppb for any individual PFAS
    • 250 ppb total PFAS (excluding polymeric PFAS)
    • 50 ppm total PFAS (including polymeric PFAS) Relevant actors must demonstrate compliance if total fluorine exceeds 50 mg F/kg.

Sector Impacts: Who’s in the Line of Fire

  • Electronics & Semiconductors
    • PFAS are critical in chip fabrication and assembly. Controlled‑use exemptions might buy time—but documentation, testing, and substitution scouting must start yesterday.
  • Medical Devices & Pharma Packaging
    • PFAS in packaging and excipients are under increased scrutiny. Alternatives must meet safety and stability thresholds or risk regulatory pushback.
  • Technical Textiles & Industrial Goods
    • Industries using PFAS for water/oil repellence, filtration, or catalyst supports will need rigorous risk assessments and potentially staggered phase‑out plans.
  • Defense, Military & Explosives
    • PFAS in protective gear, coatings, and munitions often lack viable substitutes. Controlled exemptions are on the table—but only under strict usage conditions and timelines.
  • Printing, Sealing & Machinery
    • PFAS are ubiquitous in inks, adhesives, seals, and gaskets. Redesign or substitution may be more cost-intensive than anticipated.

Funding & Alternatives

The EU is investing in PFAS-free innovation through Horizon Europe and national grants, supporting projects in textiles, coatings, and electronics. But critical sectors — semiconductors, defense, pharma — still lack commercially viable substitutes, making the RO3 “controlled-use” pathway central in the near term.

Ban, Exemptions, and New Controlled‑Use Models

Originally, the proposal centered on two scenarios:

  • RO1: Full ban with an 18-month transition
  • RO2: Ban with time-limited derogations (5–12 years, species-dependent)

Now, the dossier submitters have included RO3: conditional continued use for sectors where PFAS alternatives remain unviable but risks are demonstrated to be controlled ﹣ essentially a framework for critical industries to buy time under tight scrutiny.

If accepted, RO3 becomes a double-edged sword: it preserves functionality—but only for organizations with airtight compliance infrastructure and ongoing monitoring.

NGO Pressure & Litigation

NGOs like ChemTrust and ChemSec continue to press for a universal PFAS ban, warning against broad derogations. In 2025, Le Monde reported intense industry lobbying to narrow PFAS definitions — criticized by scientists. At the same time, PFAS lawsuits are spreading across Europe, echoing U.S. litigation, adding urgency for regulators to act.

What’s Next: RAC, SEAC & the Road to 2026

Now it’s committee time:

  • RAC (Risk Assessment Committee) will assess toxicological data, exposure, and environmental ramifications.
  • SEAC (Socio-Economic Analysis Committee) will evaluate the macro- and micro-economic impacts of restrictions or exemptions.

Once their independent opinions are issued, likely in late 2025 or early 2026, the European Commission, together with EU Member States, will determine enforcement specifics and timing.

In September 2025, RAC and SEAC reached their first provisional conclusions: – RAC: PFAS in electronics & semiconductors – SEAC: PFAS in energy & lubricants – Both: PFAS manufacturing and “horizontal issues” such as thresholds, hazard assessments, and emission controls.

Next steps: – Dec 2025 → committees revisit electronics, semiconductors, and manufacturing. – Mar 2026 → RAC adopts its final opinion, SEAC agrees on a draft opinion → launches a 60-day consultation. – End 2026 → SEAC adopts final opinion; Commission + Member States then decide.

Enforcement could start in 2026, with phased rollouts into 2027.

National Actions Inside the EU While the EU-wide restriction is still under review, some countries have already acted: – Denmark banned PFAS in food packaging (2020). – Netherlands enforced strict PFAS soil and water thresholds. – Germany restricted firefighting foams and some textiles. – Sweden banned PFAS firefighting foams in training.

These unilateral steps show regulators won’t wait for Brussels to finalize rules.

Action Plan: What Manufacturers Must Do Now

  1. Audit your PFAS footprint
    • Map PFAS-containing materials in your products and supply chain.
  2. Engage suppliers proactively
    • Push for compliance data, PFAS alternatives, and phase-out plans.
  3. Run risk and socio-economic impact assessments
    • Especially if controlled-use exemptions may apply.
  4. Prepare technical documentation and testing protocols
    • Tight thresholds like 25 ppb and 250 ppb demand analytical capability and due diligence.
  5. Join trade groups or compliance networks
    • Stay updated and influence potential modifications.

Prepare for SCIP & Digital Product Passport (DPP)

PFAS compliance will tie into SCIP database reporting (for SVHCs in articles) and Digital Product Passports (DPPs) for electronics, textiles, and other products under the Ecodesign Regulation. Companies will need integrated data systems, not siloed spreadsheets.

Conclusion

The PFAS regulatory landscape just got more formidable and more complex. Prepare or lose ground fast. Need to automate your PFAS strategy with reporting, exemptions management, and compliance documentation without dragging spreadsheets into meetings?

Acquis Compliance is built for that. Let’s talk.

Topics

PFAS

Speak to Our Compliance Experts

Questions about compliance, partnerships, or support? We're here to help.

Share

ECHA’s Updated EU PFAS Restriction Proposal: What Manufacturers Must Know

The August 2025 update significantly expands PFAS regulation under REACH by adding eight new sectors to the scope: Printing applications Sealing systems Machinery operations Pharmaceutical packaging and excipients Military and defense applications Explosives manufacturing Technical textiles Broad industrial uses such as solvents and catalysts Companies operating in these sectors now face tighter compliance obligations, including new testing, reporting, and substitution requirements.
The updated PFAS Background Document was published on 20 August 2025 by ECHA . It reflects the integration of over 5,600 scientific and technical comments collected during the 2023 public consultation and introduces expanded sector coverage, new PFAS concentration thresholds, and conditional-use pathways.
The updated proposal introduces three distinct pathways: RO1 – Full Ban: A complete prohibition of PFAS with an 18-month transition period. RO2 – Time-Limited Exemptions: Temporary derogations for specific uses, ranging from 5 to 12 years depending on sector viability and available alternatives. RO3 – Controlled Use: A new pathway allowing PFAS usage in critical sectors where risks can be tightly managed and documented, such as electronics, semiconductors, and defense systems
ECHA’s updated proposal sets stringent PFAS thresholds that manufacturers must adhere to: 25 ppb for any single PFAS compound 250 ppb total PFAS content (excluding polymeric PFAS) 50 ppm total PFAS, including polymeric PFAS Additionally, if total fluorine exceeds 50 mg F/kg , companies must provide documented testing evidence to prove compliance.
The updated Background Document is currently under review by two ECHA scientific committees: RAC (Risk Assessment Committee) → Evaluates toxicological and environmental impacts. SEAC (Socio-Economic Analysis Committee) → Analyzes economic feasibility and industry impacts. Their independent opinions are expected by late 2025 or early 2026, after which the European Commission, in consultation with EU Member States, will decide on final restrictions and enforcement timelines.
Yes, immediate preparation is critical. Organizations should: Map PFAS usage across bills of materials, packaging, and supply chains Request compliance declarations from upstream suppliers Implement analytical testing to verify threshold adherence Develop contingency plans for product redesigns or substitution Evaluate exemption eligibility if relying on PFAS for critical performance Early action will help minimize compliance costs, prevent disruption, and ensure market access within the EU/EEA.
Yes, but only if RO3 is adopted. Under this pathway, PFAS may continue to be used in electronics, semiconductors, energy systems, defense applications, and technical textiles where no viable alternatives exist. However, companies must: Provide robust risk assessments Demonstrate safe usage and controlled exposure Maintain complete technical documentation Undergo ongoing monitoring and reporting to regulators This controlled-use model is designed for critical applications but will require significant investment in compliance infrastructure.